Status:
UNKNOWN
Assessing the Utility of Ultrasound Compared to Cross-Sectional Imaging in the Follow-up of Patients With Renal Cell Carcinoma
Lead Sponsor:
University of Kansas Medical Center
Conditions:
Renal Cell Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to determine the utility of renal ultrasonography (US) in the detection of abdominal recurrences after definitive therapy for renal cell carcinoma (RCC) and compare the detect...
Eligibility Criteria
Inclusion
- Patients must be 18 year of age or older.
- Patients having undergone radical or partial nephrectomy for the indication of renal cell carcinoma.
- Most recent imaging study must have been either computed tomography (CT) or magnetic resonance imaging (MRI).
Exclusion
- Patients with pT4 disease (tumor invades beyond the Gerota fascia: including contiguous extension into the ipsilateral adrenal gland).
- Patients with metastatic disease prior to time of surgery requiring systemic treatment.
- Patients with another active cancer diagnosis requiring systemic treatment.
- Patients with contrast allergies.
- Patients with baseline chronic kidney disease (GFR \< 45 ml/min/1.73 m2).
Key Trial Info
Start Date :
July 17 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04424472
Start Date
July 17 2020
End Date
December 1 2022
Last Update
September 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kansas Health System
Kansas City, Kansas, United States, 66160